Molex acquires Ireland-based medtech molding and manufacturing supplier

Molex is part of Koch Industries, the business empire owned by David and Charles Koch, two of the richest men in the world and generous donors to conservative causes in the United States. 

"This strategic acquisition broadens the scope of our integrated medical solution offerings and significantly strengthens our medical device design, manufacturing and test capabilities," said Molex Senior Vice President, Business Development and Corporate Strategy, Tim Ruff in a prepared statement. "ProTek Medical excels in cleanroom injection molding and assembly, has an extensive metrology lab and the quality and regulatory expertise that is critical to global medical device manufacturers."

ProTek Medical will continue to operate as a subsidiary of Molex Ireland Holdings. Founded in 1995, ProTek Medical has a diverse portfolio of applications that include cardiac rhythm management components, infusion devices and vascular delivery products. 

ProTek Medical works closely with customers to ensure a seamless transition from prototype to production. Its team has built valued partnerships with a number of top-tier medical device, biotech and pharmaceutical manufacturers in Europe and North America, says the company. This acquisition also expands the Molex medical footprint to Ireland, which is one of Europe's premier medtech hubs.

"The acquisition presents new opportunities to achieve faster growth by expanding into new regions and healthcare market segments," added Frank Boyle, founder and CEO, ProTek Medical. "We will now have the ability to easily scale to serve high-mix, low- and high-volume production requirements for SME and large medical device OEM customers worldwide."